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O B J E C T I V E S We aimed to evaluate the correlation of angiographic late loss (LL) with the degree
of in-stent neointimal proliferation assessed by optical coherence tomography (OCT) and histology.
B A C KG ROUND Angiographic LL is the most common endpoint used in clinical trials for the
evaluation of the efﬁcacy of drug-eluting stents (DES). However, there are few data in regards to the
accuracy of angiographic LL in the evaluation of DES displaying lower degrees of neointimal
proliferation.
METHOD S A total of 49 stents (36 DES and 13 bare-metal stents) were deployed in coronary arteries
of 23 domestic swine and followed up for 28 or 90 days, thus obtaining different degrees of neointimal
proliferation. Each stent was divided into 8 to 9 segments along the longitudinal axis to match
corresponding histological cross sections. Angiographic LL was calculated at each segment throughout
the entire length of the stent and compared with in-stent neointimal thickness (NT) obtained by OCT and
histology.
R E S U L T S A total of 382 angiographic segments were suitable for matched comparison with both
OCT and histological ﬁndings. The mean LL at follow-up was 0.60  0.57 mm (range: 0.46 to 2.3 mm)
for all segments. Approximately 13.9% of stent segments had a LL between 0.5 and 0 mm, and 22.5%
had a LL greater than 1.0 mm. The correlation between OCT and histology for the evaluation of NT was
adequate regardless the level of angiographic LL. In addition, overall correlations between angiographic
LL and NT by OCT or histology were adequate (R  0.77 and 0.63, respectively). However, angiographic
LL showed a poor correlation with NT by OCT or histology at a value 0.55 mm (R  0.38 and 0.15,
respectively).
CONC L U S I O N S Angiographic LL below a threshold value of 0.55 mm correlates poorly with NT
obtained by OCT and histology. These results suggest a cautious interpretation is needed to evaluate
angiographic endpoints in DES trials in which LL values below this threshold are reported. (J Am Coll
Cardiol Img 2011;4:1002–10) © 2011 by the American College of Cardiology Foundation
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1003uantitative coronary angiography (QCA)
is the most common diagnostic method
used to assess the efficacy of drug-eluting
stents (DES) (1,2). Angiographic late loss
(LL) has been used as a surrogate endpoint in the
evaluation of stent efficacy in clinical trials (3). By
measuring the total amount of angiographic lumen
loss at follow-up, an indirect assessment of the
amount of neointimal proliferation formed within
the stent can be made. It has been shown that
angiographic LL seems to correlate with the occurrence
See page 1011
of important clinical events, such as binary resteno-
sis and target lesion revascularization (TLR), and
its value as a surrogate endpoint for the assessment
of restenosis propensity and stent performance has
been suggested (2–4). Following the widespread
use of DES, the degree of angiographic LL has
consistently been reported to be usually less than 0.4
mm (1), a value close to the resolution threshold of
angiography. To date, there are few data in regard
to the accuracy of angiographic LL in the evalua-
tion of DES displaying lower degrees of neointimal
proliferation. In the present study, we aimed to
determine the threshold at which angiographic LL
correlates with neointimal thickness (NT) evaluated
by in vivo optical coherence tomography (OCT)
and histology.
M E T H O D S
Study design. The study protocol was approved by
the local institutional animal care and use commit-
tee. All animals received humane care in compli-
ance with the Animal Welfare Act and the “Guide
for the Care and Use of Laboratory Animals.” A
total of 49 stents (13 Xience V [3.0 12 mm, Abbott
Vascular, Santa Clara, California], 11 Endeavor
Sprint [3.0 12 mm, Medtronic, Minneapolis, Min-
nesota], 12 Taxus Liberte [3.0  12 mm, Boston
Scientific, Natick, Massachusetts], and 13 ML Vision
[3.0  12 mm, Abbott Vascular]) were implanted in
the coronary arteries of 23 domestic swine (25 to 40
kg). All animals were divided into 2 groups according
to the length of follow-up: 28 days (n 12; 23 stents)
or 90 days (n  11; 26 stents) in order to achieve
ifferent levels of neointimal formation. At the time of
eployment, the location of each stent was systemat-
cally randomized to the coronary arteries of each
nimal.Procedural description. Animals were pre-medicated
with 325 mg of aspirin and 75 mg of clopidogrel at
least 12 h before the procedure and pre-
anesthetized with an appropriate mixture of glyco-
pyrrolate, telazol, and xylazine based on animal
weight. After an adequate anesthetic status, the
animals were intubated and inhaled isoflurane (1%
to 2%) delivered through a precision vaporizer and
a circle absorption breathing system with periodic
arterial blood gas monitoring. A vascular access
sheath (7-F) was placed in the carotid artery by
cut-down with sterile technique. Before catheter-
ization, heparin (5,000 to 10,000 U) was injected to
maintain an activated coagulation time of 250 to
300 s. Each stent deployment was with a stent-to-
artery ratio of 1.1. After vessel allocation to an
experimental group, the appropriate stent was de-
livered to the intended site over a guidewire using
fluoroscopic guidance. Following stent implanta-
tion, hemostasis was obtained by arterial
ligation using 2-0 silk suture and the
incision site closed in 2 to 3 layers with
appropriate suture material. All animals
received aspirin (81 mg) and clopidogrel
(75 mg) daily, and remained on a normal
chow diet.
Angiographic analysis protocol. Quantita-
ive coronary angiography (QCA) was
erformed at baseline, following stent im-
lantation, and at the terminal procedure
sing the QAngio XA 7.1 Medis System
Medis Medical Imaging Systems, Le-
den, the Netherlands). All angiograms
ere analyzed by an operator blinded to
oth stent type and termination time
oint. Each stent was divided into 9 segments along
he longitudinal axis to match corresponding histo-
ogical segments (Fig. 1). Each individual segment
nderwent QCA analysis for the assessment of
inimal lumen diameter (MLD) immediately post-
mplantation and at follow-up. Angiographic LL
as determined at each individual segment by
ubtracting the MLD at follow-up from the MLD
ssessed immediately post-stenting as previously
escribed (5). The MLD was considered the small-
st lumen diameter in each segment within the stent
utomatically identified by the software and confirmed
y the QCA operator. Percent diameter stenosis was
alculated according to the following formula: percent
iameter stenosis  [1  (lumen diameter/mean
eference vessel diameter)]  100.
OCT imaging protocol and analysis. OCT images
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1004(LightLab Imaging, Inc., Westford, Massachusetts)
at 28 or 90 days after stent implantation. Motorized
OCT pullbacks were performed at a rate of 1.0
mm/s. If the initial pullback was not of adequate
quality, sequential pullbacks were performed until
an optimal sequence was achieved. All images were
stored on the system hard drive for offline analysis.
Every subsequent millimeter was specified by the
OCT frame-rate, allowing for precise histological–
OCT frame matching. Stent area (SA) was defined
as the circumferential area limited by the contours
of the struts. Lumen area (LA) was defined by the
evaluator as the leading edge of the circumferential
hyper-reflective zone covering the stent struts. Neo-
intimal area was calculated by subtracting the LA
from the SA. To analyze NT, the distance between
the center of each strut and the luminal border was
measured in the direction of the stent center of
gravity. The percentage area stenosis (AS) was
calculated according to the following formula: per-
cent AS [1 (LA/SA)] 100. A stent strut was
considered covered if NT was 20 m. Complete
strut coverage was defined as 100% of struts covered
Figure 1. Representative Images for Matching Segment Betwee
Each stent at angiography was divided into 8 to 9 segments along
underwent a quantitative coronary analysis (QCA). Each stent segm
ence tomography (OCT) (A) and histological (B) section. CS  crosswith neointima thicker than 20 m in each cross section (CS). The neointimal unevenness score was
alculated in each individual CS by dividing the
aximal NT by the average NT within the same
S (6).
Tissue harvesting and histology protocol. All animals
were euthanized immediately following follow-up
imaging under general anesthesia. Hearts were
excised and pressure-perfused with 0.9% saline
followed by pressure-perfusion fixation in 10%
neutral-buffered formalin until hardening of the
heart muscle was clearly perceptible as previously
described (7,8). Prior to histological processing,
intact hearts with stented vessels were imaged by
capturing high-contrast film-based radiographs
(Faxitron X-ray Corp, Model 43855A, National
X-Ray, Lawrenceville, Georgia) to locate and assess
stent location. The stented arterial segments were
then carefully dissected. After polymerization, 8 to
9 sections, each measuring approximately 1.3 mm,
were sawed from each stent, beginning at the distal
stent edge. Individual slides were cut on a rotary
microtome at 4 to 6 m, mounted, and stained with
ematoxylin and eosin, and elastic Van Gieson
giographic LL and OCT, or Histology CS
longitudinal axis, and each individual angiographic segment
at angiography was matched to the corresponding optical coher-
tion; LL  late loss.n An
the
ent
sectains. All sections were examined by light micros-
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1005copy for the presence of inflammation, thrombus,
neointimal formation, and vessel wall injury. The
cross-sectional areas (external elastic lamina [EEL],
internal elastic lamina [IEL] and LA) of each
section were measured using ImagePro Plus 4.5
(Media Cybernetics, Bethesda, Maryland). NT was
measured as the distance from the center of each
stent strut to the luminal border in the direction of
the stent center of gravity. Area measurements were
used to calculate vessel layer areas: media (EEL area
IEL area), neointima (IEL area  LA), and %AS
(1  [LA/IEL area]  100). Complete strut
coverage was defined as 100% of struts covered with
neointima in each CS. Endothelial coverage was
semiquantified and expressed as the percentage of
the lumen circumference covered by endothelium.
Complete endothelial coverage was defined as 100%
of strut covered with endothelial cell at each CS.
Imaging coregistration protocol. Each harvested
stent was divided into 8 or 9 segments ranging
between 1.19 mm and 1.59 mm in thickness. In
order to accurately match the histological CS with
both imaging modalities, each OCT frame and
QCA measurement site was assessed at the exact
site of histological cutting. The locations of the
OCT frames were selected using the pullback speed
and frame numbers to precisely determine the
position of the in vivo image within the stent. QCA
measurements were precisely matched using the
built-in distance function within the analytical soft-
ware utilized (Fig. 1).
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Figure 2. Correlation Coefﬁcient Between Angiographic LL, NT
Each interval was divided with the value of LL within 0.1 mm of sta
Figure 1.Statistical analysis. Continuous variables were ex-
ressed as a mean  SD. Student t test was
performed to compare continuous variables; a
Mann-Whitney U test was used for skewed distri-
butions. The categorical variables were expressed as
both number and percentage, and were compared
using the chi-square test or Fisher exact-test. All
OCT measurements were performed by 2 experi-
enced operators, and their results were compared to
gauge the interobserver variability of the study.
Repeated measurements were obtained by the pri-
mary observer after 2 weeks in order to assess
intraobserver variability. Linear regression analysis
was performed on all corresponding datasets, and
the resulting correlation coefficient (R value) was
reported. To identify the optimal level of LL, which
was adequately correlated with NT by OCT or
histology, intervals were divided according to LL
value with the same standard deviation of 0.1 mm
because the Pearson correlation coefficient is depen-
dent on the standard deviation of the variables used.
We therefore tried to eliminate differences in cor-
relation coefficients between intervals that would be
due simply to between-interval differences in the
standard deviation of the LL. To minimize an effect
for this, we specified mutually exclusive and exhaus-
tive intervals of LL that had the same standard
deviation of 0.10. Using this method, we found a
cutoff value (0.55 mm of LL) to diverge the
correlation coefficient (Fig. 2). The correlation
analysis between angiographic LL and OCT or
oss (mm)
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1006histology in all and each interval (0.55 mm of
LL and 0.55 mm of LL) was analyzed using the
Spearman correlation test due to the fact that the
distribution of the data was skewed. In addition,
a nonlinear model with 95% prediction interval
was utilized to evaluate the error of fit across
ranges. Data were analyzed with the SPSS 16.0
software for Windows (SPSS, Chicago, Illinois).
A p value 0.05 was considered statistically
ignificant.
R E S U L T S
Angiographic LL analysis. A total of 49 stents were
included in the analysis, yielding a total sample of
382 angiographic stent segments that were matched
with corresponding OCT and histological imaging
frames. The average number of segments analyzed
per stent was 7.9 0.5 (range: 6 to 9 segments). By
angiography, the mean MLD immediately after
stent implantation was 2.90  0.23 mm (range:
1.95 to 3.48 mm). At follow up, the mean MLD
was 2.31 0.53 mm (range: 0.87 to 3.44 mm). The
Table 1. Morphological Parameters Assessed In Vivo by QCA an
All (n  382)
QCA
MLD at post-stent, mm 2.90 0.23
MLD at follow-up, mm 2.31 0.53
Diameter stenosis, % 22.7 16.6
LL, mm 0.60 0.57
OCT
Neointimal thickness, mm 0.28 0.22
Lumen area at follow-up, mm2 4.94 1.76
Neointimal area, mm2 2.10 1.65
Percent area stenosis, % 30.0 22.7
*Percentage of strut coverage, % 93.7 13.7
†Complete strut coverage 273/382 (71.5%)
‡Neointimal unevenness score 1.82 0.56
Histology
Neointimal thickness, mm 0.29 0.22
Lumen area at follow-up, mm2 4.18 1.61
Neointimal area, mm2 2.47 1.37
Percent area stenosis, % 37.9 20.4
*Percentage of strut coverage, % 99.4 2.9
†Complete strut coverage 362/382 (94.8%)
§Percentage of endothelial coverage, % 98.6 4.1
Complete endothelial coverage 291/382 (76.2%)
Neointimal unevenness score 1.82 0.60
Values are n (%) or mean  SD. *Percentage of strut coverage was deﬁned as
in histological CS. †Complete strut coverage was deﬁned as 100 % of strut cove
CS. ‡Neointimal unevenness score was calculated for each segment as maxima
same CS (6). §Percentage of endothelial coverage was deﬁned as % of strut co
deﬁned as 100 % strut covered with endothelial cell in histological CS.
CS  cross section; LL  late loss; MLD  minimal lumen diameter; OCT  opticamean LL at follow-up was 0.60  0.57 mm (range:
0.46 to 2.30 mm) for all examined segments
(Table 1). Approximately 13.9% of stent segments
had a LL between 0.5 and 0 mm, and 22.5% had
a LL 1 mm. Most angiographic stent segments
(63.6%) had a LL between 0 and 1.0 mm at
follow-up.
Angiographic LL and OCT correlation. The mean neo-
ntimal area was 2.10  1.65 mm2 (range: 0 to 6.60
mm2), and the mean NT was 0.28  0.22 mm
range: 0 to 1.01 mm). Approximately 82.2% of
tent segments had a NT less than 500 m.
Intraobserver variability was very low for the mea-
surement of NT and area by OCT (R  0.99 and
 0.99, respectively), as was interobserver vari-
bility (R  0.98 and R  0.98, respectively).
verall angiographic LL correlated well with NT,
eointimal area, and percent AS obtained by OCT
nalysis (R  0.77, R  0.76, and R  0.76,
espectively). However, correlation between angio-
raphic LL and NT assessed by OCT appeared to
e affected by the level of neointima proliferation.
CT, and Ex Vivo by Histology in a Total of 382 Matched CS
oup 1 (LL <0.55 mm)
(n  206)
Group 2 (LL >0.55 mm)
(n  176) p Value
2.86 0.25 2.95 0.21 0.001
2.69 0.30 1.86 0.38 0.001
12.5 11.8 34.9 12.9 0.001
0.18 0.25 1.09 0.42 0.001
0.15 0.11 0.43 0.22 0.001
5.89 1.20 3.71 1.49 0.001
1.13 0.84 3.24 1.64 0.001
16.2 13.0 46.0 21.0 0.001
88.0 16.6 98.3 6.6 0.001
113/206 (54.9%) 160/176 (90.9%) 0.001
1.99 0.61 1.64 0.45 0.001
0.18 0.15 0.42 0.22 0.001
4.98 1.33 3.23 1.37 0.001
1.77 0.84 3.30 1.40 0.001
27.1 14.6 50.6 18.9 0.001
99.0 3.7 99.8 1.6 0.003
189/206 (91.7%) 173/176 (98.3%) 0.004
98.3 4.8 99.1 3.2 0.23
153/206 (74.3%) 138/176 (78.4%) 0.34
1.96 0.66 1.66 0.47 0.001
strut covered with neointima (20 m thickness) in OCT CS or any neointima
with neointima (20 m thickness) in OCT CS or any neointima in histological
intimal thickness in one CS divided by the average neointimal thickness of the
d with endothelial cell in histological CS. Complete endothelial coverage wasd O
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1007The correlation coefficient was poor below 0.55 mm
of LL and significantly increased once LL reached
a threshold of 0.55 mm or higher when compared
with the NT values obtained by OCT (Figs. 2 and 3).
he neointimal unevenness score of OCT was
ignificantly higher in the group with 0.55 mm of
L than that with 0.55 mm of LL.
Angiographic LL and histology correlation. A sum-
ary of the histological morphometric analysis is
hown in Table 1. The mean histological in-stent
ercent diameter stenosis was 37.9  20.4% (range:
.6% to 88.6%). The mean NT obtained by histol-
gy was 0.29  0.22 mm (range: 0.01 to 0.93 mm).
Similarly, overall angiographic LL correlated rea-
sonably well with NT, neointimal area, and percent
AS obtained by histology (R 0.63, R 0.59, and
R  0.60, respectively). However, the correlation
coefficient was poor below 0.55 mm of LL and
significantly increased from 0.55 mm of angio-
graphic LL compared with NT by histology (Figs.
2 and 4). The neointimal unevenness score of
histology was also significantly higher in the
group with 0.55 mm of LL than that with
0.55 mm of LL.
OCT-histology correlation. Paired OCT and histo-
ogical findings were examined to assess their cor-
elation. Neointimal thickness (R  0.84), neoin-
imal area (R  0.80), and percent AS (R 0.86)
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Figure 3. Correlation Between Angiographic LL and NT by OCT
A nonlinear model with 95% prediction interval bands was shown
derived from Spearman correlation analysis. Abbreviations as in Figuresisplayed a high degree of correlation. The corre-
ation coefficient between both techniques was con-
tant irrespective of the level of angiographic LL
Fig. 2).
Stent strut coverage. Overall strut coverage at each
S observed by OCT and histology were 93.7 
3.7% and 99.4  2.9%, respectively. The percent-
age of struts covered by neointima at each CS found
by OCT analysis was significantly greater in the
group with LL 0.55 mm compared with those
with LL 0.55 (98.3  6.6% vs. 88.0  16.6%,
p  0.001). In addition, the frequency of complete
strut coverage at each CS was also higher in the
group with LL 0.55 mm (90.9% vs. 54.9%, p 
0.001 in OCT and 99.8% vs. 99.0%, p  0.003 in
histology, Table 1).
D I S C U S S I O N
Angiographic LL has been widely used in most
DES studies as a surrogate endpoint of device
efficacy. Its simple methodology allows the mea-
surement of the absolute level of neointimal prolif-
eration, and it has been widely adopted as a surro-
gate marker for the evaluation of in-stent restenosis
(9). In addition, several publications suggest that
this angiographic variable may accurately predict
important clinical outcomes such as TLR, thus
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1008supporting its potential value in the determination
of restenosis propensity and stent efficacy (2,10).
However, despite its widespread utilization in clin-
ical trials, the real correlation of angiographic LL
with the degree of in-stent neointimal proliferation is
still unknown. This question remains particularly im-
portant because most of the DES used today display a
level of angiographic LL that is below the threshold of
detection of coronary angiography (11).
The aim of the present study was to evaluate the
ability of angiographic LL to accurately assess the
degree of neointimal proliferation within implanted
coronary stents displaying different levels of neoin-
timal proliferation. In the study, resulting angio-
graphic LL of the stented segments was compared
with corresponding areas analyzed with OCT and
histology. Our group has previously validated the
use of OCT as a tool for the evaluation of neoin-
timal formation by comparing the resulting mor-
phological parameters with histology (8). As a
result, OCT imaging was utilized as a way to
acquire in vivo in-stent morphometric data and thus
serving as an internal control for the histology
results.
Utilizing successive correlation analysis pairing
QCA and OCT or histology at each interval of LL,
we were able to identify the level at which angio-
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Figure 4. Correlation Between Angiographic LL and NT by Histo
A nonlinear model with 95% prediction interval bands was shown
derived from Spearman correlation analysis. Abbreviations as in Figgraphic LL appropriately correlated with neointi-mal proliferation as assessed by histology and OCT.
For the entire group, the correlation between an-
giographic LL and NT determined by OCT or
histology was adequate (R  0.77 and R  0.63).
However, at lower levels of neointimal proliferation
(0.55 mm), angiographic LL had a poor correla-
tion when compared with the degree of NT ac-
quired with either OCT or histology. Our findings
suggest that differences in angiographic LL below
this threshold are difficult to interpret, particularly
when the differences described between stents tech-
nologies are minimal (range: 0.01 to 0.39 mm).
Our findings support some of the clinical data that
describe the limitations of this angiographic vari-
able. Agostoni et al. (11) reported that the use of
LL may lead to an overestimation of the risk of
restenosis when comparing different types of DES.
It was postulated that stronger evidence was needed
to confirm the reliability and reproducibility of this
method as a valid endpoint. In addition, there have
been significant discrepancies between the level of
angiographic LL and clinical outcomes in large
clinical studies (12,13). In some of these studies,
different levels of LL did not necessarily correlate
with a higher frequency of adverse clinical events
(14,15). Therefore, it has been suggested that the
utilization of LL as a surrogate endpoint may be of
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1009values range between 0 and 0.5 mm. The data from
the TAXUS-IV study suggested a marked increase
of TLR when the LL reached a threshold of 0.5
mm or higher (15). Another study showed that the
relationship between LL and TLR is exponential,
and does not become linear until LL is 0.5 mm
(4). As a consequence, several publications suggest
the need for revascularization only when the angio-
graphic LL threshold reaches this value because it
seems to more accurately correlate with future TLR
events and to a higher homogeneity within the LL
effect (a low variance of values) (15). We believe
that our findings appear to confirm this hypothesis
because a similar threshold of angiographic LL
correlated well with the degree of neointimal
growth assessed by 2 independent analytical modal-
ities.
In addition, the OCT-histology correlation dem-
onstrated good intermodality concordance irrespec-
tive of level of late loss, although some variation
occurred at a higher level of late loss. The differ-
ences encountered between histology and OCT at a
higher level of neointimal formation may be related
to the variability commonly encountered in histo-
logical analysis due to tissue shrinking and histo-
logical processing. However, regardless of these
differences, this study confirms again that the de-
gree of neointimal proliferation measured by OCT
appropriately correlated with the values determined
by histology and seems to provide more accurate
information than the standard QCA analysis, par-
ticularly in the settings of low levels of neointimal
proliferation.
Another interesting finding of this study was the
correlation of angiographic LL with strut coverage
in OCT or histology. At lower levels of LL (0.55
mm), OCT underestimated the degree of strut
coverage (54.9%) compared with histology (99.0%).
There are several reasons that can explain these
findings. First, the imaging resolution is different
between both analytical techniques. Also, there are
important differences in regard to the definitions of
strut coverage between both techniques. Although
in histology, uncovered struts are clearly identifi-
able, by OCT, the presence of uncovered struts are
defined if the neointima is 20 m (8). This
definition aims to overcome the challenge of mea-
suring a thin neointima in the presence of the
strut-derived blooming artifact (typically 37 m
n thickness bidirectionally). In any case, based on
urrent definitions, OCT appears to underestimate
he degree of strut coverage compared with histol-
gy at these levels of angiographic LL. Interest-ngly, at higher levels of LL (0.55 mm), complete
trut coverage by OCT (90.9%) was comparable to
he value encountered in histology (98.3%). There-
ore, at this level of LL, OCT appears to be a
easonable indicator of the level of strut coverage as
ompared with histology.
Study limitations. The main limitation of the study
was the experimental nature of the procedure and
the fact that stents were implanted in normal
porcine arteries. Although widely used for the
validation of stents, this model does not provide a
baseline angiographic luminal obstruction and com-
plex atherosclerotic lesion as is seen in humans.
Therefore, the results of this study need to be
interpreted with caution and within the context of
an experimental setting. However, the utilization of
this model and methodology permitted the con-
trolled analysis of all angiographic variables because
all stents started with a similar baseline angio-
graphic luminal stenosis. Another limitation relies
on the challenges of in vivo imaging, coregistration,
and histological tissue processing potentially caus-
ing some variability to the data. In addition, QCA
analysis is limited in detecting the development
patterns of neointimal growth throughout the stent.
However, in order to solve this issue, we selected
the optimal view at each stented segment, avoiding
foreshortening at the time of analysis. Identical
imaging projections were used at different time
points for QCA analysis. However, we believe that
the methodology used in our study properly ad-
dressed potential confounding variables, allowing
the proper testing of the proposed hypothesis. In
addition, the study included a large sample size,
including stents displaying a wide variety of degrees
of neointimal proliferation, allowing an accurate
statistical analysis.
C O N C L U S I O N S
In summary, the results of the present study suggest
that the accuracy of angiographic LL appears com-
promised in segments in which NT falls below 500
m, a finding consistent with the visual resolution
previously described for QCA (16). In stents dis-
playing low degrees of neointimal proliferation, the
applicability of LL calculation for restenosis evalu-
ation becomes limited due to drawbacks in image
resolution inherent to the QCA technique. Our
data suggest cautious interpretation of the results in
contemporary DES trials and support ongoing ef-
forts to identify intravascular image modalities with
resolution high enough for the detection of any
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1010level of in vivo neointimal growth following coro-
nary stent implantation. Further study is warranted
to evaluate these findings in more detail and their
applicability in human coronary arteries.
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